Jill Wilken

1.7k total citations
19 papers, 1.2k citations indexed

About

Jill Wilken is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Jill Wilken has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Virology and 4 papers in Infectious Diseases. Recurrent topics in Jill Wilken's work include HIV Research and Treatment (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Chemical Synthesis and Analysis (4 papers). Jill Wilken is often cited by papers focused on HIV Research and Treatment (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Chemical Synthesis and Analysis (4 papers). Jill Wilken collaborates with scholars based in United States, Switzerland and Italy. Jill Wilken's co-authors include Stephen B. H. Kent, Darren A. Thompson, Gregory S. Barsh, Laurent Picard, Ira Gantz, Michael A. Weiss, Robin E. Offord, Donald E. Mosier, Lingyang Zhu and Chris J. Dickinson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Jill Wilken

19 papers receiving 1.1k citations

Peers

Jill Wilken
Dianne Alewood Australia
Paul J. Laybourn United States
Grace E. Ungers United States
Nancy Villa United States
Valerie M. Tesmer United States
Xavier Cayla France
Renaud Wagner France
Jennifer Lippincott‐Schwartz United States
Robson L. Melo Brazil
Steven J. Bark United States
Dianne Alewood Australia
Jill Wilken
Citations per year, relative to Jill Wilken Jill Wilken (= 1×) peers Dianne Alewood

Countries citing papers authored by Jill Wilken

Since Specialization
Citations

This map shows the geographic impact of Jill Wilken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Wilken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Wilken more than expected).

Fields of papers citing papers by Jill Wilken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Wilken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Wilken. The network helps show where Jill Wilken may publish in the future.

Co-authorship network of co-authors of Jill Wilken

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Wilken. A scholar is included among the top collaborators of Jill Wilken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Wilken. Jill Wilken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Miranda, Les P., Haiyan Shao, Shiah-Yun Chen, et al.. (2007). A Chemical Approach to the Pharmaceutical Optimization of an Anti-HIV Protein. Journal of the American Chemical Society. 129(43). 13153–13159. 11 indexed citations
2.
Hartley, Oliver, Hubert Gaertner, Jill Wilken, et al.. (2004). Medicinal chemistry applied to a synthetic protein: Development of highly potent HIV entry inhibitors. Proceedings of the National Academy of Sciences. 101(47). 16460–16465. 132 indexed citations
3.
Alexeev, Dmitry, Paul N. Barlow, Jean‐Damien Charrier, et al.. (2003). Synthesis, Structural and Biological Studies of Ubiquitin Mutants Containing (2S, 4S)‐5‐Fluoroleucine Residues Strategically Placed in the Hydrophobic Core. ChemBioChem. 4(9). 894–896. 28 indexed citations
4.
Hua, Qing‐xin, Satoe H. Nakagawa, Jill Wilken, et al.. (2003). A divergent INS protein inCaenorhabditis elegansstructurally resembles human insulin and activates the human insulin receptor. Genes & Development. 17(7). 826–831. 47 indexed citations
5.
Zhu, Lingyang, et al.. (2002). Sex-specific Gene Regulation. Journal of Biological Chemistry. 277(45). 43463–43473. 27 indexed citations
6.
Fernandez, Elias J., Aristidis Sachpatzidis, Jill Wilken, et al.. (2001). CCR2 and CCR5 receptor‐binding properties of herpesvirus‐8 vMIP‐II based on sequence analysis and its solution structure. European Journal of Biochemistry. 268(10). 2948–2959. 5 indexed citations
7.
McNulty, Joseph C., Darren A. Thompson, Kimberly A. Bolin, et al.. (2001). High-Resolution NMR Structure of the Chemically-Synthesized Melanocortin Receptor Binding Domain AGRP(87−132) of the Agouti-Related Protein,. Biochemistry. 40(51). 15520–15527. 69 indexed citations
8.
Marcaurelle, Lisa A., Laura S. Mizoue, Jill Wilken, et al.. (2001). Chemical Synthesis of Lymphotactin: A Glycosylated Chemokine with a C-Terminal Mucin-Like Domain. Chemistry - A European Journal. 7(5). 1129–1132. 2 indexed citations
9.
Marcaurelle, Lisa A., Laura S. Mizoue, Jill Wilken, et al.. (2001). Chemical Synthesis of Lymphotactin: A Glycosylated Chemokine with a C-Terminal Mucin-Like Domain. Chemistry - A European Journal. 7(5). 1129–1132. 84 indexed citations
10.
Fernandez, Elias J., Jill Wilken, Darren A. Thompson, Stephen C. Peiper, & Elias Lolis. (2000). Comparison of the Structure of vMIP-II with Eotaxin-1, RANTES, and MCP-3 Suggests a Unique Mechanism for CCR3 Activation,. Biochemistry. 39(42). 12837–12844. 29 indexed citations
11.
Zhu, Lingyang, Jill Wilken, Nelson B. Phillips, et al.. (2000). Sexual dimorphism in diverse metazoans is regulated by a novel class of intertwined zinc fingers. Genes & Development. 14(14). 1750–1764. 152 indexed citations
12.
Panzer, Ulf, André Schneider, Jill Wilken, et al.. (1999). The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney International. 56(6). 2107–2115. 59 indexed citations
13.
Rusconi, Stefano, Donatella Arienti, Daria Trabattoni, et al.. (1999). Aminooxypentane-RANTES, an Inhibitor of R5 Human Immunodeficiency Virus Type 1, Increases the Interferon gamma to Interleukin 10 Ratio without Impairing Cellular Proliferation. AIDS Research and Human Retroviruses. 15(10). 861–867. 4 indexed citations
14.
Thompson, Darren A., Chris J. Dickinson, Jill Wilken, et al.. (1999). Characterization of Agouti-Related Protein Binding to Melanocortin Receptors. Molecular Endocrinology. 13(1). 148–155. 155 indexed citations
15.
Bolin, Kimberly A., Darren A. Thompson, Jill Wilken, et al.. (1999). NMR structure of a minimized human agouti related protein prepared by total chemical synthesis. FEBS Letters. 451(2). 125–131. 67 indexed citations
16.
Wilken, Jill, David M. Hoover, Darren A. Thompson, et al.. (1999). Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES. Chemistry & Biology. 6(1). 43–51. 62 indexed citations
17.
Mosier, Donald E., Gastón Picchio, Richard J. Gulizia, et al.. (1999). Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants. Journal of Virology. 73(5). 3544–3550. 152 indexed citations
18.
Fernandez, Elias J., Jill Wilken, Darren A. Thompson, et al.. (1998). Accessibility of selenomethionine proteins by total chemical synthesis: structural studies of human herpesvirus‐8 MIP‐II. FEBS Letters. 441(1). 77–82. 16 indexed citations
19.
Wilken, Jill & Stephen B. H. Kent. (1998). Chemical protein synthesis. Current Opinion in Biotechnology. 9(4). 412–426. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dianne Alewood Breakdown of academic impact, for papers by Paul J. Laybourn Breakdown of academic impact, for papers by Grace E. Ungers Breakdown of academic impact, for papers by Nancy Villa Breakdown of academic impact, for papers by Valerie M. Tesmer Breakdown of academic impact, for papers by Xavier Cayla Breakdown of academic impact, for papers by Renaud Wagner Breakdown of academic impact, for papers by Jennifer Lippincott‐Schwartz Breakdown of academic impact, for papers by Robson L. Melo Breakdown of academic impact, for papers by Steven J. Bark
Rankless by CCL
2026